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Background: Several studies investigated transitions and risk factors from impaired glucose tolerance (IGT) to type
2 diabetes mellitus (T2D). However, there is a lack of information on the probabilities to transit from normal glucose
tolerance (NGT) to different pre-diabetic states and from these states to T2D. The objective of our study is to
estimate these risk equations and to quantify the influence of single or combined risk factors on these transition
probabilities.
Methods: Individuals who participated in the VIP program twice, having the first examination at ages 30, 40 or
50 years of age between 1990 and 1999 and the second examination 10 years later were included in the analysis.
Participants were grouped into five groups: NGT, impaired fasting glucose (IFG), IGT, IFG&IGT or T2D. Fourteen
potential risk factors for the development of a worse glucose state (pre-diabetes or T2D) were investigated: sex,
age, education, perceived health, triglyceride, blood pressure, BMI, smoking, physical activity, snus, alcohol, nutrition
and family history. Analysis was conducted in two steps. Firstly, factor analysis was used to find candidate variables;
and secondly, logistic regression was employed to quantify the influence of the candidate variables. Bootstrap
estimations validated the models.
Results: In total, 29 937 individuals were included in the analysis. Alcohol and perceived health were excluded due
to the results of the factor analysis and the logistic regression respectively. Six risk equations indicating different
impacts of different risk factors on the transition to a worse glucose state were estimated and validated. The impact
of each risk factor depended on the starting or ending pre-diabetes state. High levels of triglyceride, hypertension
and high BMI were the strongest risk factors to transit to a worsened glucose state.
Conclusions: The equations could be used to identify individuals with increased risk to develop any of the three
pre-diabetic states or T2D and to adapt prevention strategies.
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Type 2 diabetes mellitus (T2D) is a severe disease with
considerable impact on people’s wellbeing and standard
of living. Worldwide prevalence of T2D is high and ex-
pected to further increase in the coming years [1]. The
age-standardized incidence rate of T2D in a Swedish
community between 1971 and 2001 was 3.03 cases per
100 000 [2]. The age-standardized prevalence of T2D
was 2.56% for women in 1971 and 4.07% in 2001 and
2.17% for men in 1971 and 3.93% in 2001 [2]. The an-
nual mean cost of care for a patient with T2D in Sweden
was estimated to 3 602 EUR with inpatient care consu-
ming the most resources [3]. Risk factors associated with
the development of T2D are, among others, obesity, low
level of physical activity or low intake of fruits and vege-
tables [4-6]. Fortunately, T2D is preventable. Several
studies have shown that the development of T2D can be
prevented or delayed by lifestyle modification [4,5,7].
Lifestyle intervention to prevent T2D is at least as effect-
ive as pharmacological treatment [6]. In a meta-analysis,
studies estimated a pooled effect for all forms of lifestyle
interventions with a hazard ratio of 0.51 (95% confi-
dence interval 0.44 to 0.60), indicating a relative risk re-
duction of 49% for the development of T2D [6].
The natural history of T2D describes the process of
the development from normal glucose tolerance (NGT)
via so-called pre-diabetic states, which are characterized
by higher insulin resistance and/or reduced insulin se-
cretion, to T2D. The pre-diabetic or worsened glucose
states are impaired fasting glucose (IFG), impaired
glucose tolerance (IGT) and a combination of both
(IFG&IGT). Subjects in any of the three states have
moderate to severe insulin resistance and impaired insu-
lin secretion, each state having distinct pathophysiologic
etiologies. For a description of the states see DeFronzo
and colleagues [8]. Assuming relatively short intervals,
for example one year, the direct development of T2D
from NGT is not likely. At some point of time, the indi-
vidual will develop IGT, IFG or a combination of both
before a possible transition to T2D. It is therefore intri-
guing and necessary to specifically look at pre-diabetic
states and factors that influence their development. Pre-
diabetes is an increasingly common condition [9]. It has
been reported that subjects with IFG differ from those
with IGT or with a combination of both. We need stu-
dies that estimate the specific impact of glycemic states
on the development of T2D and that determined which
factors are driving forces for this development.
Several high-quality studies exist on the transitions
and its risk factors from IGT to T2D [7,10]. However,
no study has yet investigated the probability of moving
from NGT to pre-diabetic states and from these states
to T2D. In a previous investigation, we found no study
that included probabilities of moving among all thenecessary states needed in a diabetes prevention model,
such as NGT, IGT and/or IFG and which was based on
one population [11].
The Västerbotten Intervention Program (VIP) was ini-
tiated in 1985 with the aim to reduce morbidity and
mortality from cardiovascular disease and diabetes [12].
Within this program, people at ages 40, 50 and 60 living
in the Swedish county of Västerbotten were invited to a
health assessment and health counseling conducted by
their primary care provider [12]. Thirty-year olds were
also included until 1996. Every tenth year, people living
in the included area were invited again and the same
measurements were taken. Part of this screening was an
oral glucose tolerance test, which is the gold standard
for the diagnosis of T2D as well as of IGT&IFG. This
test was conducted according to standards of the World
Health Organization with a 75 g oral glucose load. Mea-
surements on height, weight, blood pressure, plasma
lipids and an oral glucose tolerance test were performed,
and each VIP participant was asked to complete a set of
questionnaires, including questions about physical acti-
vity, tobacco use and dietary habits. The VIP was de-
scribed in more detail elsewhere [12].
The objective of this study was to calculate risk
equations that predict 10-year transition probabilities
from NGT to pre-diabetic states and from pre-diabetic
states to T2D taking major risk factors into consideration.
Methods
Individuals who participated in the VIP program twice,
having the first examination at ages 30, 40 or 50 years of
age between 1990 and 1999 and the second examina-
tion 10 years later were included in the analysis. Data
from the regional diabetes registry DiabNorth [13] were
linked to the VIP dataset and information was com-
pared. Among patients with diabetes, 74% consented to
be included in the DiabNorth register. Subjects with a
diagnosis of type 1 diabetes mellitus were excluded. If
the DiabNorth indicated that a person had IGT or T2D
maximal two years before or after the VIP examination,
the information from the DiabNorth registry replaced
the glucose status of the VIP. Otherwise additional
DiabNorth information was ignored. Participants were
grouped into NGT, IFG, IGT, IFG&IGT or T2D by
WHO classification (1999) according to the results of
the oral glucose tolerance test [14].
Fourteen potential risk factors for the development of
a worse glucose state (pre-diabetes or T2D) were inves-
tigated. Table 1 describes all potential risk factors con-
sidered in the study.
The analysis was conducted in two steps. Firstly, factor
analysis was used to find candidate variables; and se-
condly, logistic regression was employed to quantify the
influence of the candidate variables.
Table 1 Description of risk factors under investigation, Västerbotten Intervention Program
Variable Values Description
Sex Male / female
Age Years of age, each decade includes one year older and younger, e.g.
30 = 29–31 years of age etc.
Education High / middle / low University OR education of >12 years in school / 10–12 years of
education in school / compulsory school OR < 10 years of
education in school
Marital status Married OR living with spouse / single Single = not married OR widowed OR divorced
Perceived health Good / bad Questionnaire of well-being, original score: very good, pretty good,
somewhat good, pretty bad, bad; first two were merge to “good”
and latter three to “bad”
Triglyceride Normal / high Triglyceride levels: ≤ 1.69 / ≥ 1.7 mmol/l
Blood pressure Normal / high Systolic blood pressure < 140 mmHg and diastolic blood
pressure < 90 mmHg AND no self-reported anti-hypertensive drug /
self-reported anti-hypertensive drug OR systolic blood
pressure≥ 140 mmHg OR diastolic blood pressure≥ 90 mmHg
Body mass index (BMI) Underweight & normal / overweight / obesity calculation: (weight in kg) / (height in m)2: ≤ 24.9 / 25.0 – 29.9 / ≥ 30.0
Smoking status Never / formerly / present
Physical activity Physically active / moderately active / sedentary Physically active = exercise at least 2–3 times/week or walk and/or
cycle more than 3 times/week during leisure time or walk or cycle
to work more than 5 km per way
Moderately active = do exercise now and then but not regularly or
cycle and/or walk during their leisure time at least 2–3 times per
week or cycle and/or walk to work 2–5 km each way
Sedentary = never exercise or walk and/or cycle during their leisure
time less than 2–3 times per week or take bus or car to work or
cycle and/or walk to work less than 2 km per way.
Snus No current use / ≤ 4 cans per week / > 4 cans
per week
Snus is an oral non-smoking tobacco that is commonly used in
Sweden. It is put into the mouth, usually underneath the upper lip.
The biological effect of snus use is different from smoking [15].
Alcohol abuse Normal / risk of harmful alcohol consumption Test for harmful alcohol consumption (CAGE questionnaire: 0–1 / 2–4)
5 a day At least 5 a day / less than 5 a day The average consumption of the following fruits and vegetables
was summed (based on Food Frequency Questionnaire): berries
(fresh or frozen), apples / pears / peaches / oranges / grape,
bananas, carrots, tomatoes / cucumbers, salad / spinach / broccoli;
At least 5 a day = at least five portions of the above fruits and/or
vegetables per day
Less than 5 a day = less than five portions of the above fruits and/or
vegetables per day
Family history No parents and or siblings with T2D / parents or
siblings with T2D
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tor analysis was used to exclude multicollinear variables.
Factor analysis is a statistical method that describes
variability among observed, correlated variables in terms
of a potentially lower number of unobserved variables
called factors [16]. It describes the relation between vari-
ables. Factor loadings reveal the extent to which each of
the variables contributes to the meaning of each of the
factors. Uniqueness is the variance that is “unique” to
the variable and not shared with other variables. Variables
in our analysis were kept if they fulfilled any of the follow-
ing “keep-conditions” of having either the highest factorload for one factor, low factor loadings (below ±0.55) [17]
or uniqueness above 0.5.
Logistic regression (binary) was used to derive transi-
tion probabilities for movements between each of the
two states. Stepwise logistic regression analyses, using
backwards elimination, with a significance level of 0.2
were conducted for all possible transition probabilities
here [18]. In backwards elimination, the method first in-
cludes all variables and step-by-step eliminates variables
until no omitted variable would have contributed signifi-
cantly to the model. Thus, the p-values of individual pa-
rameters are compared with the “stay-level”, which was
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elimination prevents the model to exclude too many
variables.
The results are given as odds ratios (OR) with their 95%
confidence intervals (95% CI). Coefficients are employed
for risk equations (see Additional file 1). Risk equations
describe the relationship between the possible risk factors
stating the likelihood of moving from one state to another.
The relationship can be expressed by ORs or coefficients.
ORs above 1 or coefficients above zero state an increased
risk for an increase of the variable.
To validate the results, the bootstrap technique was
used [19]. We drew, with replacement, as many individ-
uals as the sample size from our data. The 95% CIs of
the coefficients based on 1 000 repetitions was estimated
by the percentile method. It was tested whether zero lied
without the 95% CIs.
The software program STATA/SE 11.0 (StataCorp LP,
College Station, TX) was used for analyses. SAS 9.22
(SAS Institute Inc., Cary, NC) was used for the visua-
lization of ORs and CIs. Ethical approval for this stu-
dy was received from the Regional Ethics Board Dnr
08-131 M at Umeå University, Sweden. All subjects




In total, 29 937 individuals were included in the analysis.
Table 2 shows the age and sex distribution of the study
population. Most participants were 40 or 50 years of age
at their first examination. About half of the participants
(53%) were women.
Figure 1 shows the glucose states during the first exa-
mination and during the follow-up examination in the
VIP, which was 10 years later. Row percentages indicate
the development of glucose states in individuals after ten
years. The blue cells (dashed frame) in Figure 1 are al-
ways larger than the equivalent green complementary
cells (double solid frame). This indicates that in each
situation more cases move forward in the natural history
of the development of T2D than backwards. We found
that 12%, 4% and 2% of those individuals with NGT at
first examination had moved to IFG, IGT and IFG&IGT,
respectively. Further, 14%, 17% and 49% moved to T2D
starting from IFG, IGT or IFG&IGT, respectively. Most
individuals, however, remained in the glucose state of
their first examination (NGT: 78%, T2D: 61%).
Test to prevent multicollinearity
Factor analysis determined that the variable “risk for
harmful alcohol consumption” needs to be excluded
from the model as it did not fulfill any of the necessary
“keep-conditions” (Table 3). Factor 1 was determined by“sex” (factor loading (fl): -0.75) and “snus” (fl: 0.67).
“Snus” had uniqueness above 0.5. Factor 2 contained the
variables “age” (fl: 0.70) and “blood pressure” (fl: 0.67).
“Blood pressure” had uniqueness above 0.5. The variable
“smoking” (fl: 0.79) represented Factor 3. Factor 4 was
described by “perceived health” (fl: 0.74). Factor 5 did
not entail a variable with a high factor loading. “Educa-
tion”, “marital status”, “triglycerides”, “BMI”, “physical
activity”, “consumption of at least 5 portions of fruits or
vegetables a day” and “family history” revealed fair to
poor factor loadings (below ±0.55). All seven variables
were kept in the model due to their relatively low chance
for multicollinearity. Only the highest factor loading of
each variable is displayed (Table 3).
Establishment of risk equations
The results of stepwise logistic regressions for the in-
dividual contribution of each risk factor with backwards
elimination are shown in Table 4. See Additional file 1 for
risk equations with coefficients. The reference (OR = 1)
for each variable is specified. The backwards regression
analyses removed those risk factors from the 13 potential
factors in every model equation that did not fulfill the 0.2
significance level. The variable perceived health was ex-
cluded in every of the six regression models through back-
wards elimination and is consequently not included in
further analyses. Odds ratios and 95% CIs for each risk
factor and each transition are shown in a logarithmic scale
in Figure 2a and b.
The low number of individuals who had IFG&IGT at
baseline examination lowered the chance of statistical
significance. In fact, only BMI was statistically significant
in the transition from IFG&IGT to T2D.
With the tools created here, it is possible to calculate
different scenarios adapting a specific risk profile. For
example, the change in risk could be estimated for a
woman with increased consumption of fruits and vegeta-
bles, a change from high levels of triglyceride to normal
levels, a change from hypertension to normal blood
pressure and a reduction of weight (Additional file 1).
We can estimate how the risk to develop any of the
worsened glucose states or T2D changes by altering any
of the risk factors in the model.
Discussion
This study developed risk equations from healthy (NGT)
to pre-diabetic states and from pre-diabetes states to
T2D using data of a Swedish population. In total, six risk
equations were developed and validated. The equations
can be used to identify individuals with increased risk to
develop any of the three pre-diabetic states or T2D. In
addition, the equations are useful for adapting preven-
tion strategies to specific risk profiles. Risk models are
widely used in clinical and public health practice [20].
Table 2 Description of Västerbotten Intervention
Program population at first examination (n = 29 937)
Variable Number %
Sex
Male 13 968 46.7
Female 15 969 53.3
Missing 0 0
Age
30 years 4 917 16.4
40 years 12 218 40.8
50 years 12 802 42.8
Missing 0 0
Education
High 7 386 24.7
Middle 15 854 53.0
Low 6 353 21.2
Missing 344 1.1
Marital status
Married/living with spouse 24 794 82.8
Single 4 786 16.0
Missing 357 1.2
Perceived health
Good 22 727 75.9
Bad 6 646 22.2
Missing 564 1.9
Triglyceride
Normal 18 928 63.2
High 4 551 15.2
Missing 6 458 21.6
Blood pressure
Normal 23 138 77.3
High 6 500 21.7
Missing 299 1.0
Body mass index (BMI)
Underweight & normal 16 281 54.4
Overweight 10 692 35.7
Obesity 2 784 9.3
Missing 180 0.6
Smoking status
Never 13 753 45.9
Formerly 8 721 29.1
Present 6 976 23.3
Missing 487 1.6
Physical activity
Physically active 4 018 13.4
Moderately active 20 115 67.2
Table 2 Description of Västerbotten Intervention
Program population at first examination (n = 29 937)
(Continued)
Sedentary 5 384 18.0
Missing 420 1.4
Snus
No current use 24 927 83.3
≤ 4 cans per week 3 293 11.0
> 4 cans per week 973 3.3
missing 744 2.5
Alcohol abuse
Normal 22 927 76.6
Risk of harmful alcohol consumption 1 799 6.0
Missing 5 211 17.4
5 a day
At least 5 a day 2 203 7.4
Less than 5 a day 20 303 67.8
Missing 7 431 24.8
Family history
No parents or siblings with T2D 24 273 81.1
Parents or siblings with T2D 4 994 16.7
Missing 670 2.2
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risk of developing a pre-diabetic state from being healthy
as well as developing T2D depending on modifiable and
non-modifiable risk factors. The risk equations allow ad-
justment to a specific risk profile and thus give more
precise risk estimates than general risk models.
We found that 49% of those with IFG&IGT at baseline
developed T2D in comparison to 3%, 14% and 17% for
those with NGT, IFG and IGT (Figure 1). Other pro-
spective studies have also found that a combination of
IFG and IGT increases the risk of developing T2D com-
pared to subjects having either of the glycemic abnor-
malities [9,21-23]. For example, de Vegt and colleagues
estimated that the ORs for T2D were 10.1, 10.9 and
39.5 for those having IFG, IGT and IFG&IGT, res-
pectively [21].
From the results of the logistic regression, it seems
that the variables snus and sex as well as the variables
education and smoking might show multicollinearity.
However, we have examined the influence of each pair
of risk factors and could not find that this first impres-
sion was true. All four potential risk factors were hence
kept in the logistic regression estimations. We also
compared whether OR coefficients and their equivalent
bootstrap results in all logistic regression models were
significantly different from 1. Besides the variables age
and triglyceride in the transition from NGT to IFG as
Glucose state at follow-up









































































a Follow-up was 10 years after first examination
Figure 1 Glucose states during first examination in the Västerbotten Intervention Program and at follow-upa.
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NGT to IFG&IGT and from IGT to T2D, all other varia-
bles could be validated with the bootstrap estimations.
Risk factors
In our study, sex had different influence on the progres-
sion to a pre-diabetic state. Whereas men have a higher
risk to develop IFG, women have higher risk to develop
IGT. As expected, the progression from NGT to IGT
and/or IFG exhibits striking sex differences [24-26]. In
most populations, IFG is substantially more common
amongst men and IGT is slightly more common amongst
women [26,27]. In a study from Turkey, however, IFG and
IGT were more common in women than in men [27].
Meigs and colleagues reported that men in comparison toTable 3 Results from factor analysis showing highest factor lo












Risk of Harmful Alcohol Consumptione 0.57
5 a daybcdf
Family historycd
aNumbers in bold signify the highest factor loading of each factor.
bHighest factor loading of factor.
cVariable with factor loadings below ±0.55. Variable will be kept in the model.
dVariable with uniqueness above 0.5. Variable will be kept in the model.
eVariable removed.
f5 a day = consumption of at least five portions of fruits and vegetables a day.women had a higher risk to progress from NGT to IFG
and/or IGT in the United States [28].
As expected, increasing age increases the likelihood to
develop a worse diabetic state. Even though age is a
non-modifiable risk factor, it needs to be included in all
risk equations.
Our data suggest that lower education increases the
risk to develop IFG from NGT, even tough the confi-
dence interval of the odds ratio is quite close to one
(non-significance). Nonetheless, education might be an
important player in prevention of a pre-diabetic state.
Self-rated health was excluded from all six risk equa-
tions indicating that it did not add to the models. How-
ever, T2D is known to be related to low self-rated health
[29,30]. However, our results might be due to a smallading and uniqueness per variablea















Table 4 Odds ratios (95% confidence interval) of risk to progression to another state by risk factors, stepwise logistic regression (backwards elimination,
significance level = 0.2)
Risk factors
From state
A to state B























NGT to IFG 0.75a (0.67-0.84) 1.01a (>1.00-1.02) 1.11a
(1.03-1.21)
1.17a (1.02-1.33) 1.12 (0.99-1.28) 1.17a (1.03-1.27) 1.26a (1.18-1.35) n.a. 0.92
(0.82-1.03)
n.a. n.a. 1.21a (1.07-1.36)
n = 15 473
NGT to IGT 1.67a (1.41-1.97) 1.06a (1.05-1.07) 1.10
(0.98-1.23)
1.50a (1.24-1.81) 1.40a (1.18-1.67) 1.24a (1.11-1.39) 0.89a (0.80-0.98) 1.16a
(>1.00-1.33)
n.a. n.a. n.a. 1.16 (0.98-1.38)
n = 15 473
NGT to
IFG&IGT




0.72 (0.52- > 1.00) n.a. 1.37a (1.11-1.69)
n = 15 473
IFG to T2D 0.65a (0.45-0.92) 1.05a (1.02-1.09) n.a. 1.35 (0.95-1.93) 1.85a (1.29-2.64) 1.78a (1.39-2.27) n.a. n.a. n.a. 1.58 (0.82-3.05) 1.43
(0.93-2.20)
1.66 (0.83-3.33)
n = 1 299




0.54 (0.24-1.23) n.a. n.a. n.a. n.a. 2.04a (1.20-3.45) 1.52 (0.88-2.63) n.a. n.a. 0.35 (0.08-1.43) n.a. 2.40 (0.98-5.87)
n = 120
a Statistically significant (5% significance level, Wald-test).
Sex (1 = male, 2 = female), Education (1 = high, 2 =middle, 3 = low), Perceived health (1 = very good, pretty good, 2 = somewhat good, pretty bad, bad), Triglyceride (0 = normal (TG ≤ 1.69 mmol/l), 1 = high
(TG ≥ 1.7 mmol/l)), Blood pressure (0 = normal (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg and no self-reported anti-hypertensive drug), 1 = self-reported anti-hypertensive drug OR
systolic blood pressure ≥ 140 mmHg OR diastolic blood pressure ≥ 90 mmHg), BMI (1 = underweight/normal (≤ 25), 2 = overweight (25–29.9), 3 = obese/severely obese (≥ 30)), Smoking (1 = never, 2 = formerly,
3 = present), Physical activity (0 = physically active (exercise at least 2–3 times/week or walk and/or cycle more than 3 times/week during leisure time or walk or cycle to work more than 5 km per way), 1 = moderately
active (do exercise now and then but not regularly or cycle and/or walk during their leisure time at least 2–3 times per week or cycle and/or walk to work 2–5 km each way), 2 = sedentary (never exercise or walk and/
or cycle during their leisure time less than 2–3 times per week or take bus or car to work or cycle and/or walk to work less than 2 km per way), Snus (1 = no current use, 2 =maximal 4 cans/week, 3 =more than 4
cans/week), Alcohol (0 = no risk of harmful alcohol consumption, 1 = risk of harmful alcohol consumption), 5 a day (1 = at least five portions of fruits or vegetables per day, at 2 = less than five portions of fruits or
vegetables per day), Marital status (1 = married or living with spouse, 2 = single or widowed or divorced), Family history (1 = no parents and/or siblings with T2D, 2 = parents and siblings with T2D).





















Figure 2 a: Odds ratios (OR) of progression from NGT to IFG, IGT and IFG&IGT and their 95% confidence intervals by risk factors in a
logarithmic scale; b: Odds ratios (OR) of progression from IFG, IGT and IFG&IGT to T2D and their 95% confidence intervals by risk
factors in a logarithmic scale.
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to difficulties in measuring self-rated health.
As expected, high triglyceride levels, high blood pres-
sure and high BMI are the strongest factors for a pro-
gression to a worse diabetic state. All are well-known
risk factors for the development of T2D. In a study by
Jauch-Chara and colleagues, low body weight was associ-
ated with increased risk to develop IGT from NGT [31].
Underweight could not be examined separately in our
study but was combined with normal weight due to the
low number of cases in the underweight category. The
influence of low body weight could thus not be esti-
mated with our data. Our risk models assume a linear
relationship looking only at increased body weight. In
another study, BMI and waist circumference were higher
in subjects with abnormalities of glucose metabolism
compared to NGT [32]. A study from the United States
also found that higher BMI increased the rate to pro-
gress from NGT to IFG and/or IGT [28].
The odds ratio of smoking was above 1 for the deve-
lopment of NGT to IFG and below 1 for the develop-
ment of NGT to IGT. In a study with American Indians,
participants with pre-diabetes reported significantly less
smoking than participants with NGT and were signi-
ficantly more likely to be past smokers [9]. However, in
our study smokers and past-smokers were relatively
evenly distributed at first examination. Our population
included 24%, 29%, 19%, 21% and 29% smokers and
29%, 31%, 30%, 37% and 29% past-smokers among NGT,IFG, IGT, IFG&IGT and T2D respectively. In addition,
smoking is related to lower BMI. Smoking prevalence
has decreased and prevalence of high BMI has increased
over time in this population. Individuals must have,
therefore, quit smoking between baseline and follow-up.
Smoking cessation might lead to an increased in weight
and BMI [33]. Possibly, BMI could also be the explana-
tory factor here.
Lower level of physical activity (vs. higher level) slightly
increased the risk to develop IGT from NGT. This is con-
sistent with the literature [4,5].
The odds ratios of snus, “five a day” and marital status
were all not significant. We aimed to describe diet with
one simple variable in our model. However, the question
what is healthy diet is difficult to answer. The purpose
of the variable we created was that it needed to be sim-
ple and easy to understand. We decided to use the con-
sumption of five portions of fruits and vegetables a day
as a proxy of healthy diet, knowing that this is a simplifi-
cation of reality. Diet is far more complex.
Marital status did not have any significant impact on
the development of a worsened glucose status. It was
only included in the model IFG to T2D but could not
reach statistical significance.
In our population, individuals with a family history of
diabetes developed a worsened glucose status more
likely than those without a family history of diabetes.
This factor was only excluded in the development from
IGT to T2D. An evaluation of the Stockholm Diabetes
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lence of IFG, similarly to the prevalence of IGT, IFG and
IGT combined and T2D, was nearly twofold higher in
those who had a family history of T2D compared to
those without family history of T2D [32]. It needs to be
kept in mind that knowledge about family medical status
and age of respondent might have been important influ-
ences on whether the study participant reported a family
history of T2D. For example, it has been shown in our
VIP population that knowledge about family history is
rather low, in particular among younger men [34]. In
addition, parents of young study participants might not
have been diagnosed with T2D yet [34].
In consequence, the influence of specific risk factors on
the transition to worse states towards the development of
T2D is diverse. Different risk factors have different impacts
on the development of IFG, IGT, IFG&IGTand T2D.
Use of results in practice
Once glucose status has been estimated, information
used to perform risk equations are relatively easy to ob-
tain, for example age, smoking status or measurement of
BMI. For the classification of the glucose status, an oral
glucose tolerance test is needed. This need of a test is a
challenge, because in a practical setting the individual or
their physician rarely knows the patient’s glucose status.
The advantage of our risk equations over similar risk tools
is that four different glucose states can be represented,
establishing six unique risk equations [33]. Other risk equa-
tions focused on the development of T2D only [35-37].
As Noble and colleagues pointed out, caution is
needed when extrapolating risk models to a different po-
pulation [20]. The models, therefore, best describe the
Swedish population. Risk equations should be evaluated
to determine whether they are also valid in other popu-
lations and in other prospective cohorts.
Combined risk
Comparing our results without looking at risk factors
leads us back to Figure 1. Among individuals with IFG
or IGT at baseline, 14% and 17%, respectively, developed
T2D 10 years later. For those with a combination of IFG
and IGT the risk was much higher. Almost half (49%) of
our population with IFG&IGT at baseline developed
T2D within 10 years. Our overall one-year risks for T2D
(estimated based on 10-year changes within our co-
hort [38]) were 1.5%, 1.8% and 6.5% for IFG, IGT and
IFG&IGT respectively.
In other studies, the annual progression rates to T2D
were 1-5% for individuals with IFG and 3-11% for those
with IGT [21,23,39,40]. The Hoorn study estimated that
the annual rate of developing T2D from IFG alone was
5.5%, and from IFG together with IGT 10.8% [21]. The
Paris Prospective Study reported a much lower annualrate, with 1% for individuals with IFG and 6% for indi-
viduals with IFG and IGT [22]. An Italian study esti-
mated an annual rate of 0.8% to develop diabetes from
IFG alone and an annual rate of 3.9% to develop diabetes
from a combination of IFG and IGT [23]. A study from
Iran showed that patients with first-degree relatives with
T2D have a risk of 8.6% to progress to IFG and a risk of
3.7% to progress to IGT [41]. Our results are compar-
able with the Paris Prospective Study and the Italian
study. Nonetheless, these different risks point out that
the risk profile of different populations is quite diverse.
We examined a Swedish population from a population-
based perspective, meaning that we did not aim at any
high-risk profile population but intended to investigate
the general public. This might be one reason why pro-
gression rates in our study are rather low in comparison
with other studies. The highest risk to develop T2D was
presented by combined IFG and IGT [42]. Further, VIP
participants have participated in interventions that
aimed at the reduction of T2D and cardiovascular disease.
They had experienced motivational counseling regarding
life style modification. This might have contributed to
comparable low rates of progression.
Limitations
Even though a high number of individuals could be
enclosed in this modeling study, some risk equations
only included a small number of study participants, such
as in the risk equation from IFG&IGT to T2D. This def-
initely hampered the ability to depict variables as poten-
tial risk factors.
Due to the design of the VIP, the number of people
with T2D is likely to be underestimated. We included
only panel data with information at baseline and 10 years
follow-up. If a person was diagnosed with T2D at first or
between first and second examination, he or she was less
likely to participate in the VIP or in the second VIP exam-
ination. As a consequence, more people can be expected
to be in T2D at baseline and at follow-up. However, any
change in status between first and second examination of
those individuals who participated twice were caught by
the DiabNorth register. Also, our risk equations only con-
sider worsening of the glucose state, not the reverse direc-
tion towards a less deteriorated glucose state.
In addition, we could only calculate risk over a 10-year
period. Many events can happen during such a long time
period. For example, individuals who would have deve-
loped any pre-diabetic state after some years could have
progressed to T2D within the 10 years or someone has
been in a pre-diabetic state and returned to NGT after
10 years. Also, a substantial number of individuals with
IFG or IGT revert back to NGT [43]. These changes
between the states within the 10-year time frame could
not be traced in our study, unless the participant was
Neumann et al. BMC Public Health 2013, 13:1014 Page 10 of 11
http://www.biomedcentral.com/1471-2458/13/1014included in the diabetes registry. The progression to
another state, nonetheless, takes many years. Meigs and
colleagues suggest that subjects with IFG and IGT are
already close to transitioning to T2D and underline that
T2D develops slowly over many years, transitioning
through a prolonged state of impaired glycemia [28].
Also, individuals who were registered in the DiabNorth
register would have been traced and re-sorted according
to information in the DiabNorth.
Conclusion
Our research has established and validated risk equations
describing the development from a healthy individual to a
pre-diabetic state, and from a pre-diabetic state to T2D. It
clearly shows that, on the one hand, the risk to develop a
worsened glucose state depends on the glucose state at
baseline. On the other hand, the risk also depends on se-
veral well-established risk factors whose influence differs
depending on the glucose state at baseline.
The equations are based on a population from the
north of Sweden and are expected to work well in other
parts of Europe, too. However, the models need to be
confirmed for other populations. The risk equations help
to describe an individual risk. They quantify the influ-
ence of modifiable and non-modifiable risk factors. This
will help to investigate the influence of single and com-
bined risk factors on the development of T2D through
its pre-diabetic states.
As the number are small in some risk equations, such
as for IFG&IGT to T2D, further studies on the influence
of specific glucose statuses on the development of wor-
sened glucose status are needed to finally advance pre-
vention and treatment in this area.
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